Tag Archives: Webcasts Presentations

Business, Finance, Occupation & Industry

Frontier Communications Corporation Updates Participation in Investor Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Frontier Communications Corporation Updates Participation in Investor Conference

STAMFORD, Conn.–(BUSINESS WIRE)– Frontier Communications Corporation (NAS: FTR) will participate in Goldman Sachs TMT Leveraged Finance Conference 2013. Robert Starr, Senior Vice President and Treasurer, is scheduled to present today, Wednesday, March 20, 2013 at 4:20 p.m. eastern. An earlier press release noted the presentation time as 4:30 p.m.

A live webcast of this presentation will be available at www.frontier.com/ir under “Webcasts & Presentations.”

About Frontier Communications

Frontier Communications Corporation (NAS: FTR) is an S&P 500 company and is included in the FORTUNE 500 list of America’s largest corporations. Frontier offers broadband, voice, satellite video, wireless Internet data access, entertainment services like TumTiki.com, data security solutions, bundled offerings and specialized bundles for residential customers, small businesses and home offices and advanced communications for medium and large businesses in 27 states. Frontier’s approximately 14,700 employees are based entirely in the United States. More information is available at www.frontier.com.

Frontier Communications Corporation
Robert Starr, 203-614-5708
SVP & Treasurer
robert.starr@ftr.com
or
Brigid Smith, 203-614-5042
AVP, Corporate Communications
brigid.smith@ftr.com

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:

The article Frontier Communications Corporation Updates Participation in Investor Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Frontier Communications Corporation to Participate in Investor Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Frontier Communications Corporation to Participate in Investor Conference

STAMFORD, Conn.–(BUSINESS WIRE)– Frontier Communications Corporation (NAS: FTR) is scheduled to participate in the Goldman Sachs TMT Leveraged Finance Conference 2013. Robert Starr, Senior Vice President and Treasurer, is scheduled to present on Wednesday, March 20, 2013 at 4:30 p.m. eastern.

A live webcast of this presentation will be available at www.frontier.com/ir under “Webcasts & Presentations.”

About Frontier Communications

Frontier Communications Corporation (NAS: FTR) is an S&P 500 company and is included in the FORTUNE 500 list of America’s largest corporations. Frontier offers broadband, voice, satellite video, wireless Internet data access, entertainment services like TumTiki.com, data security solutions, bundled offerings and specialized bundles for residential customers, small businesses and home offices and advanced communications for medium and large businesses in 27 states. Frontier’s approximately 14,700 employees are based entirely in the United States. More information is available at www.frontier.com.

Frontier Communications Corporation
Robert Starr, 203-614-5708
SVP & Treasurer
robert.starr@ftr.com
or
Brigid Smith, 203-614-5042
AVP, Corporate Communications
brigid.smith@ftr.com

KEYWORDS:   United States  North America  Connecticut  New York

INDUSTRY KEYWORDS:

The article Frontier Communications Corporation to Participate in Investor Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Synageva BioPharma™ Reports 2012 Full Year Financial Results

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Synageva BioPharma™ Reports 2012 Full Year Financial Results

LEXINGTON, Mass.–(BUSINESS WIRE)– Synageva BioPharma Corp. (“Synageva”) (NAS: GEVA) , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today reported 2012 full year financial results and provided 2013 financial guidance. Synageva’s management team will host a conference call today at 4:30 p.m. EDT to review the financial results and provide a general business update. To participate in today’s call via telephone, please dial (877) 312-5514 for U.S. callers, or (970) 315-0452 for international callers. In addition, the conference call will be webcast live from the “Webcasts & Presentations” section of the Investor Relations tab on the home page of Synageva’s website at www.synageva.com.

“2012 marked our first full year as a public company. Synageva made significant progress in advancing our lead program, sebelipase alfa. We announced recently that enrollment has started in the ARISE global, Phase 3 trial. This was a key step towards providing an effective therapy to patients suffering from LAL Deficiency,” said Sanj K. Patel, President and Chief Executive Officer of Synageva. “We continue to advance our other preclinical programs, and we entered 2013 with a strong cash balance which will be thoughtfully and strategically allocated to facilitate the achievement of our goals for 2013 and beyond.”

Recent Company Highlights

Synageva reported progress and updates on a number of key objectives during the past year including the following:

  • Presentation of three, six and nine-month data from the ongoing Phase 1/2 extension study of sebelipase alfa in adults with late onset lysosomal acid lipase deficiency (LAL Deficiency), including acceptance for publication of 12-week data in the journal Hepatology
  • Publication of recent prevalence estimates of late onset LAL Deficiency in the online version and an upcoming print edition of the journal Hepatology
  • Interactions with U.S., European and other global regulatory authorities that allowed us to begin clinical trial site initiations and dosing of the first patient in the Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) global, Phase 3 trial of sebelipase alfa in children and adults with LAL Deficiency in February 2013
  • Continuation of treatment and enrollment in the Phase 2/3 trial of sebelipase alfa in infants with early onset LAL Deficiency

    • …read more
    Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Synageva BioPharma™ to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on M

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Synageva BioPharma™ to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 11

LEXINGTON, Mass.–(BUSINESS WIRE)– Synageva BioPharma Corp. (Synageva) (NAS: GEVA) , a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, will report 2012 fourth quarter and full year financial results after the NASDAQ Market closes on Monday, March 11, 2013. Synageva management will conduct a conference call and audio webcast to discuss these results as well as provide a general business update at 4:30 p.m. EST on the same day.

The dial-in number for the conference call is (877) 312-5514 for U.S. callers, or (970) 315-0452 for international callers, and reference conference ID: 95417172. A live webcast of the call will be available from the “Webcasts & Presentations” section of the Investor Relations tab on the home page of Synageva’s website at www.synageva.com.

About Synageva’s Lead Program

Sebelipase alfa (SBC-102) is a recombinant form of the human LAL enzyme under development by Synageva as an enzyme replacement therapy for LAL Deficiency, a lysosomal storage disorder (LSD). Synageva is currently evaluating sebelipase alfa in global clinical trials for both early and late onset LAL Deficiency. Sebelipase alfa has been granted orphan designations by the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and the Japanese Ministry of Health, Labour and Welfare. Additionally, sebelipase alfa received “fast track” designation by the FDA.

About LAL Deficiency

LAL Deficiency is a rare autosomal recessive LSD caused by a marked decrease in LAL enzyme activity. Late onset LAL Deficiency, sometimes called Cholesteryl Ester Storage Disease (CESD), affects both children and adults. In these patients, the buildup of fatty material in the liver and blood vessel walls may lead to liver cirrhosis, liver failure and accelerated atherosclerotic events. Early onset LAL Deficiency, sometimes called Wolman disease, affects infants and is characterized by severe malabsorption, growth failure and liver failure, and is usually fatal within the first six months of life. There are no approved pharmacological therapies for LAL Deficiency. Success with stem cell and liver transplant appears to be limited by procedure-related morbidity and mortality.

About Synageva BioPharma Corp.
…read more
Source: FULL ARTICLE at DailyFinance